658 related articles for article (PubMed ID: 25433836)
1. Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome.
Dharamsi FM; Michener MD; Dharamsi JW
J Emerg Med; 2015 May; 48(5):551-4. PubMed ID: 25433836
[TBL] [Abstract][Full Text] [Related]
2. Clinical resemblance of widespread bullous fixed drug eruption to Stevens-Johnson syndrome or toxic epidermal necrolysis: report of two cases.
Lin TK; Hsu MM; Lee JY
J Formos Med Assoc; 2002 Aug; 101(8):572-6. PubMed ID: 12440088
[TBL] [Abstract][Full Text] [Related]
3. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features.
Cho YT; Lin JW; Chen YC; Chang CY; Hsiao CH; Chung WH; Chu CY
J Am Acad Dermatol; 2014 Mar; 70(3):539-48. PubMed ID: 24388722
[TBL] [Abstract][Full Text] [Related]
4. A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption.
Anderson HJ; Lee JB
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577848
[TBL] [Abstract][Full Text] [Related]
5. Detecting Lesional Granulysin Levels for Rapid Diagnosis of Cytotoxic T lymphocyte-Mediated Bullous Skin Disorders.
Chen CB; Kuo KL; Wang CW; Lu CW; Chung-Yee Hui R; Lu KL; Chang WC; Chen WT; Yun F; Teng YC; Lee HE; Lin JY; Ho HC; Chi MH; Yu-Wei Lin Y; Chang CJ; Lin Y; Ku CL; Hung SI; Chang YC; Chung WH;
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1327-1337.e3. PubMed ID: 33039642
[TBL] [Abstract][Full Text] [Related]
6. Generalized bullous fixed drug eruption imitating toxic epidermal necrolysis: a case report and literature review.
Mitre V; Applebaum DS; Albahrani Y; Hsu S
Dermatol Online J; 2017 Jul; 23(7):. PubMed ID: 29469697
[TBL] [Abstract][Full Text] [Related]
7. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Harr T; French LE
Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
[TBL] [Abstract][Full Text] [Related]
8. Acute blistering diseases on the burn ward: Beyond Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Richer V; Bouffard D; Bélisle A; Duranceau L; Perreault I; Provost N
Burns; 2013 Sep; 39(6):1290-6. PubMed ID: 23597847
[TBL] [Abstract][Full Text] [Related]
9. Bullous fixed drug eruption: A potential diagnostic pitfall: a study of 18 cases.
Zaouak A; Ben Salem F; Ben Jannet S; Hammami H; Fenniche S
Therapie; 2019 Oct; 74(5):527-530. PubMed ID: 31006486
[TBL] [Abstract][Full Text] [Related]
10. Widespread bullous fixed drug eruption mimicking toxic epidermal necrolysis.
Baird BJ; De Villez RL
Int J Dermatol; 1988 Apr; 27(3):170-4. PubMed ID: 3286546
[TBL] [Abstract][Full Text] [Related]
11. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
[TBL] [Abstract][Full Text] [Related]
12. Widespread bullous fixed drug eruption.
Patell RD; Dosi RV; Shah PC; Joshi HS
BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24510691
[TBL] [Abstract][Full Text] [Related]
13. Fixed Drug Eruptions: An Update, Emphasizing the Potentially Lethal Generalized Bullous Fixed Drug Eruption.
Patel S; John AM; Handler MZ; Schwartz RA
Am J Clin Dermatol; 2020 Jun; 21(3):393-399. PubMed ID: 32002848
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Lipowicz S; Sekula P; Ingen-Housz-Oro S; Liss Y; Sassolas B; Dunant A; Roujeau JC; Mockenhaupt M
Br J Dermatol; 2013 Apr; 168(4):726-32. PubMed ID: 23413807
[TBL] [Abstract][Full Text] [Related]
15. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
[TBL] [Abstract][Full Text] [Related]
16. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
Teraki Y; Shibuya M; Izaki S
Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
[TBL] [Abstract][Full Text] [Related]
17. Stevens-Johnson syndrome with sulfasalazine treatment: report of two cases.
Tremblay L; Pineton de Chambrun G; De Vroey B; Lavogiez C; Delaporte E; Colombel JF; Cortot A
J Crohns Colitis; 2011 Oct; 5(5):457-60. PubMed ID: 21939920
[TBL] [Abstract][Full Text] [Related]
18. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
[TBL] [Abstract][Full Text] [Related]
19. Stevens-johnson Syndrome and Toxic Epidermal Necrolysis: An Overview of Diagnosis, Therapy Options and Prognosis of Patients.
Garg VK; Buttar HS; Bhat SA; Ainur N; Priya T; Kashyap D; Tuli HS
Recent Adv Inflamm Allergy Drug Discov; 2023; 17(2):110-120. PubMed ID: 37605396
[TBL] [Abstract][Full Text] [Related]
20. Multifocal bullous fixed drug eruption mimicking Stevens-Johnson syndrome.
Rai R; Jain R; Kaur I; Kumar B
Indian J Dermatol Venereol Leprol; 2002; 68(3):175-6. PubMed ID: 17656930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
